Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
62M
-
Number of holders
-
109
-
Total 13F shares, excl. options
-
48.3M
-
Shares change
-
-5.47M
-
Total reported value, excl. options
-
$58.4M
-
Value change
-
-$6.82M
-
Put/Call ratio
-
0.65
-
Number of buys
-
51
-
Number of sells
-
-74
-
Price
-
$1.21
Significant Holders of MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) as of Q2 2025
154 filings reported holding MGNX - MACROGENICS INC - Common Stock, par value $0.01 per share as of Q2 2025.
MACROGENICS INC - Common Stock, par value $0.01 per share (MGNX) has 109 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.3M shares
of 62M outstanding shares and own 77.87% of the company stock.
Largest 10 shareholders include Bellevue Group AG (9.92M shares), ARMISTICE CAPITAL, LLC (5.96M shares), VANGUARD GROUP INC (4.21M shares), WASATCH ADVISORS LP (3.25M shares), Frazier Life Sciences Management, L.P. (3.18M shares), ACADIAN ASSET MANAGEMENT LLC (2.49M shares), MILLENNIUM MANAGEMENT LLC (2.02M shares), BlackRock, Inc. (1.82M shares), EcoR1 Capital, LLC (1.6M shares), and RENAISSANCE TECHNOLOGIES LLC (1.33M shares).
This table shows the top 109 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.